Plant activators are compounds that protect plants from pathogens by activating their immune system. In contrast to commonly used pesticides that directly target pathogens, plant activators are not pathogen specific; thus, pathogens have not developed resistance to these agents, and these activators have been proved to be durable in the field. A commonly used plant activator, benzothiadiazole (BTH), is a synthetic analog of salicylic acid (SA), a phytohormone essential for resistance against biotrophic pathogens.[@R1]^-^[@R3] Probenazole is another plant activator that has been used for more than 30 y to protect paddy-field rice in East Asia from blast fungus and bacterial leaf blight.[@R4] Probenazole does not have the SA analog activity, but is known to increase disease resistance in plants.[@R5]^,^[@R6]

Although many bioactive compounds that prime plant immunity have been found thus far, only few practical plant activators have been developed.[@R7]^,^[@R8] In order to explore a wide variety of molecules with the aim of obtaining more effective compounds that are applicable over a broad range of crops, several high-throughput chemical screening procedures have been developed. These approaches use Arabidopsis seedlings in combination with a promoter reporter system for defense genes as markers of activity.[@R9]^,^[@R10] However, the compounds that constitutively activate defense responses are often associated with arrested growth and reduction in yield.[@R11]^-^[@R14] To avoid this dilemma, new screening approaches need to be developed.

We have previously established a novel screening system for chemicals that prime immunity, but that do not induce hypersensitive cell death,[@R15] using a model plant-microbe interaction system that involves Arabidopsis suspension-cultured cells and a bacterial pathogen, *Pseudomonas syringae* pv *tomato* DC3000 *avrRpm1* (*Pst-avrRpm1*).[@R16]^-^[@R18] After screening a commercial library of 10,000 structurally diversified small organic molecules, we isolated 5 plant immune-priming compounds. These immune-inducing compounds were classified into groups A and B, according to their molecular structure, and were designated Imprimatin A1, A2, A3, B1, and B2 ([Fig. 1A](#F1){ref-type="fig"}).[@R15] We demonstrated that these compounds could inhibit both a known and a previously unknown SA glucosyltransferase (SAGT) in vitro in a SA-competitive manner, and enhance disease resistance in Arabidopsis plants to both virulent and avirulent strains of *Pst* by increasing SA accumulation during pathogen infection.[@R15]

![**Figure 1.** Molecular structures and chemical effects of Imprimatins. (A) Chemical structures of Imprimatins A1, A2, A3, B1, B2, B3, and B4. (B) The effects of Imprimatin B3 and B4 on cell death of Arabidopsis suspension-cultured cells upon inoculation with *Pst-avrRpm1*. For each compound, chemicals and bacteria were applied as indicated in the right panel. Cell death was measured as the concentration of Evans blue dye extracted from samples after staining. As mock treatments, MgCl~2~ was added instead of pathogen. The level of cell death was presented as a value relative to the mean value of the control (*Pst* + DMSO) of each experimental group (as 100) (n = 4). (C) Disease resistance against avirulent and virulent *Pst* strains induced by the treatment of Arabidopsis plants with Imprimatins. Seedlings, hydroponically grown on rockwool for 3 weeks under short-day conditions, were drenched in water supplemented with each chemical individually (100 µM) for 3 d. This was followed by *Pst* strain inoculation into the leaves by a needleless syringe. Bacterial growth inside the leaves was measured 3 d post-inoculation (n = 4). \*\* p \< 0.01; Student's t-test. (D) The effects of Imprimatins on germination and seedling growth. Arabidopsis seeds were germinated in liquid MS media supplemented with the indicated concentrations of the Imprimatin compounds.](psb-7-1526-g1){#F1}

Here, we identified another plant immune-priming compound and further obtained a bioactive molecule from derivative analysis of commercially available compounds ([Fig. 1A](#F1){ref-type="fig"}). These were designated as Imprimatin B3 and B4, respectively, because they shared a similar structure as Imprimatin B1 and B2. Imprimatin B3 and B4 upregulated *Pst-avrRpm1*-induced cell death in Arabidopsis suspension-cultured cells in a concentration-dependent manner, as did SA and tiadinil ([Fig. 1B](#F1){ref-type="fig"}). These compounds also enhanced the disease resistance of Arabidopsis seedlings against both avirulent and virulent strains of *Pst* when hydroponically grown seedlings were treated with 100 µM of Imprimatin compound by the root-drenching method for 3 d before inoculation ([Fig. 1C](#F1){ref-type="fig"}). Unlike previously identified Imprimatin A and B compounds, which target SAGTs in Arabidopsis, Imprimatin B3 and B4 had a very weak inhibitory effect on SAGT activity in vitro compared with other Imprimatin compounds ([Table 1](#T1){ref-type="table"}). The IC~50~ values of Imprimatin B3 and B4 for SAGT inhibition are apparently higher than their effective concentrations for cell death potentiation as revealed in [Figure 1B](#F1){ref-type="fig"}. Considering the molecular similarity among Imprimatin B compounds and their ability to prime immune responses in Arabidopsis, Imprimatin B3 and B4 may be converted to more effective molecules for SAGT inhibition inside the plants, through an as-yet unknown metabolic pathway(s).

###### **Table 1.** IC~50~ values of Imprimatin B3 and B4 for SAGTs in Arabidopsis

           IC~50~ (µM)     
  -------- -------------- ----------------
  **B3**   155.3 ± 12.6      84.8 ± 11.7
  **B4**   163.4 ± 32.0   136.7 ± 22.0

Inhibitory effects of Imprimatins on UGT74F1 and UGT76B1 were determined from 4 experiments. Data are expressed as mean (SD).

We also evaluated the effect of the Imprimatin compounds on plant growth ([Fig. 1D](#F1){ref-type="fig"}). Arabidopsis seeds were germinated and grown in liquid MS media containing Imprimatins at a concentration of 50 or 100 µM. In contrast to tiadinil, which markedly inhibited seedling growth, Imprimatin A2 and group-B Imprimatin compounds showed only moderate growth inhibitory effects, in a concentration-dependent manner, similar to that observed with SA. Imprimatin A1 and A3 did not affect growth at the concentration range effective for immune priming. These results suggest that further exploration of derivatives of these Imprimatin compounds may lead to isolation of appropriate compounds as practical plant activators, which target SA metabolism to enhance disease resistance.
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